Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness

preprint OA: closed
Full text JSON View at publisher
AI-generated summary by claude@2026-07, 2026-07-14

Multiplexed immunohistochemistry mapped melanoma immune landscapes, revealing spatially localized T cell exhaustion and a T cell-macrophage interaction network predicting immunotherapy response.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-07, 2026-07-14 · read from full text

The study examined how spatial immune interactions in metastatic melanoma relate to responsiveness to immune checkpoint-based immunotherapy, using multiplexed immunohistochemistry to map immune cell distributions in tumor tissues from responders versus non-responders. The authors found that cytotoxic T cells gradually adopt an exhausted phenotype as they approach and infiltrate tumors, and they identified a functional interaction network between T cells and PD-L1+ macrophages. They report that integrating the spatial distributions of these two cell populations can predict anti-PD-1 response with high confidence, while noting that the work is a preprint and has not been peer reviewed. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract While immune checkpoint-based immunotherapy (ICI) shows spectacular clinical results in cancer patients, only a subset of the these respond favorably to such treatment. Response to ICI is dictated by the integration of complex networks of cellular interactions between malignant and non-malignant cells. Although new insights into the mechanisms that modulate the pivotal anti-tumoral activity of cytotoxic T-cells (Tcy) have recently been gained, much of what we have learned is based on single-cell analyses of dissociated tumor samples; therefore, we lack critical information about the spatial distribution of the relevant cell types. Here, we used multiplexed immunohistochemistry to spatially characterize the immune landscape of metastatic melanoma from responders vs non-responders to ICI. By creating such high-dimensional pathology maps, we show that Tcy gradually evolve towards an exhausted phenotype as they approach and infiltrate the tumor. Moreover, our analysis revealed a key cellular interaction network that functionally links Tcy and PD-L1+ macrophages. Critically, mapping the respective spatial distribution of these two cell populations predict response to anti-PD-1 immunotherapy with high confidence. We conclude that baseline measurements of the spatial context should be integrated in the design of predictive biomarkers to identify patients likely to benefit from ICI.
Full text 16,509 characters · extracted from preprint-html · click to expand
Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Article Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness Francesca Bosisio, Asier Antoranz, Yannick Van Herck, Maddalena Bolognesi, and 9 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-1236531/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract While immune checkpoint-based immunotherapy (ICI) shows spectacular clinical results in cancer patients, only a subset of the these respond favorably to such treatment. Response to ICI is dictated by the integration of complex networks of cellular interactions between malignant and non-malignant cells. Although new insights into the mechanisms that modulate the pivotal anti-tumoral activity of cytotoxic T-cells (Tcy) have recently been gained, much of what we have learned is based on single-cell analyses of dissociated tumor samples; therefore, we lack critical information about the spatial distribution of the relevant cell types. Here, we used multiplexed immunohistochemistry to spatially characterize the immune landscape of metastatic melanoma from responders vs non-responders to ICI. By creating such high-dimensional pathology maps, we show that Tcy gradually evolve towards an exhausted phenotype as they approach and infiltrate the tumor. Moreover, our analysis revealed a key cellular interaction network that functionally links Tcy and PD-L1+ macrophages. Critically, mapping the respective spatial distribution of these two cell populations predict response to anti-PD-1 immunotherapy with high confidence. We conclude that baseline measurements of the spatial context should be integrated in the design of predictive biomarkers to identify patients likely to benefit from ICI. Full Text Additional Declarations There is NO Competing Interest. Supplementary Files SupplementaryTable1Overviewclinicalsamplesincludedforanalysis.docx Supplementary Table 1 SupplementaryTable2OverviewantibodiesusedforMILAN.docx Supplementary Table 2 SupplementaryTable3Cellcomposition.docx Supplementary Table 3 SupplementaryTable4GLSNanostring.xlsx Supplementary Table 4 SupplementaryTable5GSANanostring.xlsx Supplementary Table 5 Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-1236531","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Article","associatedPublications":[],"authors":[{"id":79412193,"identity":"cd974534-d1f9-4e12-932c-b2107bad5023","order_by":0,"name":"Francesca Bosisio","email":"data:image/png;base64,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","orcid":"","institution":"Translational Cell \u0026 Tissue Research, Department of Imaging and Pathology, KU Leuven, Leuven, Belgium","correspondingAuthor":true,"prefix":"","firstName":"Francesca","middleName":"","lastName":"Bosisio","suffix":""},{"id":79412194,"identity":"3197440e-a949-4332-be8d-787a99fab4be","order_by":1,"name":"Asier Antoranz","email":"","orcid":"","institution":"KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Asier","middleName":"","lastName":"Antoranz","suffix":""},{"id":79412195,"identity":"2821b447-d82e-4e22-9d03-776fa31770f7","order_by":2,"name":"Yannick Van Herck","email":"","orcid":"","institution":"KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Yannick","middleName":"Van","lastName":"Herck","suffix":""},{"id":79412196,"identity":"b7b5e032-de72-495f-85ea-82445d228a80","order_by":3,"name":"Maddalena Bolognesi","email":"","orcid":"","institution":"University of Milano-Bicocca","correspondingAuthor":false,"prefix":"","firstName":"Maddalena","middleName":"","lastName":"Bolognesi","suffix":""},{"id":79412197,"identity":"1c5bf1ca-eef3-421d-b313-cfa20eb4b7db","order_by":4,"name":"Seodhna Lynch","email":"","orcid":"","institution":"University College Dublin","correspondingAuthor":false,"prefix":"","firstName":"Seodhna","middleName":"","lastName":"Lynch","suffix":""},{"id":79412198,"identity":"d3a9cb0f-eba1-4302-8d3a-0d703d461600","order_by":5,"name":"Arman Rahman","email":"","orcid":"","institution":"University College Dublin","correspondingAuthor":false,"prefix":"","firstName":"Arman","middleName":"","lastName":"Rahman","suffix":""},{"id":79412199,"identity":"c1d24d25-d3d4-4b12-a6ef-d0d39805ad22","order_by":6,"name":"William Gallagher","email":"","orcid":"","institution":"University College Dublin","correspondingAuthor":false,"prefix":"","firstName":"William","middleName":"","lastName":"Gallagher","suffix":""},{"id":79412200,"identity":"e9b46e60-a574-4192-9f7c-19b1fe76800e","order_by":7,"name":"Veerle Boecxstaens","email":"","orcid":"","institution":"KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Veerle","middleName":"","lastName":"Boecxstaens","suffix":""},{"id":79412201,"identity":"d9e97046-6a8b-4a1f-99fc-7c6c1b04853a","order_by":8,"name":"Jean-Christophe Marine","email":"","orcid":"","institution":"VIB-KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Jean-Christophe","middleName":"","lastName":"Marine","suffix":""},{"id":79412202,"identity":"fd1751b9-beef-4052-8ef3-053791a5dde2","order_by":9,"name":"Giorgio Cattoretti","email":"","orcid":"","institution":"Universita' degli Studi Milano-Bicocca","correspondingAuthor":false,"prefix":"","firstName":"Giorgio","middleName":"","lastName":"Cattoretti","suffix":""},{"id":79412203,"identity":"2fdb8075-64bf-46e1-8bda-16b2672445c6","order_by":10,"name":"Joost van den Oord","email":"","orcid":"","institution":"KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Joost","middleName":"van den","lastName":"Oord","suffix":""},{"id":79412204,"identity":"c9714d30-9924-4b4f-b398-7a81af5e20f5","order_by":11,"name":"Frederik De Smet","email":"","orcid":"https://orcid.org/0000-0002-6669-3335","institution":"Laboratory for Precision Cancer Medicine, Translational Cell and Tissue Research, Department of Imaging \u0026 Pathology, KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Frederik","middleName":"","lastName":"De Smet","suffix":""},{"id":79412205,"identity":"98658f6c-a5c5-45d3-a5cb-850ee4d9f848","order_by":12,"name":"Oliver Bechter","email":"","orcid":"","institution":"KU Leuven","correspondingAuthor":false,"prefix":"","firstName":"Oliver","middleName":"","lastName":"Bechter","suffix":""}],"badges":[],"createdAt":"2022-01-06 22:00:40","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-1236531/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-1236531/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":18077713,"identity":"88e6be9b-40b4-4bcb-8ef4-9ddf006c05ce","added_by":"auto","created_at":"2022-02-09 21:15:19","extension":"pdf","order_by":1,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":3674130,"visible":true,"origin":"","legend":"Article File","description":"","filename":"Manuscriptnatcom.pdf","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1_covered.pdf"},{"id":18077709,"identity":"4ebf81dd-202a-441f-b41e-0a79af307bf6","added_by":"auto","created_at":"2022-02-09 21:15:02","extension":"docx","order_by":1,"title":"","display":"","copyAsset":false,"role":"supplement","size":18360,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table 1\u003c/p\u003e","description":"","filename":"SupplementaryTable1Overviewclinicalsamplesincludedforanalysis.docx","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1/f4188b94e36de559a21edebb.docx"},{"id":18077708,"identity":"d03f696c-5645-42a8-b5a6-6698adfeeb0c","added_by":"auto","created_at":"2022-02-09 21:15:02","extension":"docx","order_by":2,"title":"","display":"","copyAsset":false,"role":"supplement","size":37915,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table 2\u003c/p\u003e","description":"","filename":"SupplementaryTable2OverviewantibodiesusedforMILAN.docx","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1/bccd42d1228afdadaacd67f4.docx"},{"id":18077712,"identity":"b7bca080-c13e-4fcd-88ae-2ca75d737c38","added_by":"auto","created_at":"2022-02-09 21:15:03","extension":"docx","order_by":3,"title":"","display":"","copyAsset":false,"role":"supplement","size":17387,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table 3\u003c/p\u003e","description":"","filename":"SupplementaryTable3Cellcomposition.docx","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1/4c113ef6dce91435dd946e9c.docx"},{"id":18077711,"identity":"a79634a7-d7fd-46c2-8334-b8d8ea654c3b","added_by":"auto","created_at":"2022-02-09 21:15:02","extension":"xlsx","order_by":4,"title":"","display":"","copyAsset":false,"role":"supplement","size":79826,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table 4\u003c/p\u003e","description":"","filename":"SupplementaryTable4GLSNanostring.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1/0f2d891f4fdce8fe1cd8f93b.xlsx"},{"id":18077710,"identity":"d9c70af0-ec2e-491f-9b29-7c7d038e768c","added_by":"auto","created_at":"2022-02-09 21:15:02","extension":"xlsx","order_by":5,"title":"","display":"","copyAsset":false,"role":"supplement","size":45431,"visible":true,"origin":"","legend":"\u003cp\u003eSupplementary Table 5\u003c/p\u003e","description":"","filename":"SupplementaryTable5GSANanostring.xlsx","url":"https://assets-eu.researchsquare.com/files/rs-1236531/v1/6ddc8ab38de05f106bdc8e3c.xlsx"}],"financialInterests":"There is \u003cb\u003eNO\u003c/b\u003e Competing Interest.","formattedTitle":"Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness","fulltext":[{"header":"Full Text","content":"This preprint is available for \u003ca href='/article/rs-1236531/latest.pdf' target='_blank'\u003edownload as a PDF\u003c/a\u003e."}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":false,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":true,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":true,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"","lastPublishedDoi":"10.21203/rs.3.rs-1236531/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-1236531/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"While immune checkpoint-based immunotherapy (ICI) shows spectacular clinical results in cancer patients, only a subset of the these respond favorably to such treatment. Response to ICI is dictated by the integration of complex networks of cellular interactions between malignant and non-malignant cells. Although new insights into the mechanisms that modulate the pivotal anti-tumoral activity of cytotoxic T-cells (Tcy) have recently been gained, much of what we have learned is based on single-cell analyses of dissociated tumor samples; therefore, we lack critical information about the spatial distribution of the relevant cell types. Here, we used multiplexed immunohistochemistry to spatially characterize the immune landscape of metastatic melanoma from responders vs non-responders to ICI. By creating such high-dimensional pathology maps, we show that Tcy gradually evolve towards an exhausted phenotype as they approach and infiltrate the tumor. Moreover, our analysis revealed a key cellular interaction network that functionally links Tcy and PD-L1+ macrophages. Critically, mapping the respective spatial distribution of these two cell populations predict response to anti-PD-1 immunotherapy with high confidence. We conclude that baseline measurements of the spatial context should be integrated in the design of predictive biomarkers to identify patients likely to benefit from ICI.","manuscriptTitle":"Mapping the immune landscape in metastatic melanoma reveals localized cell-cell interactions correlating to immunotherapy responsiveness","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2022-02-09 21:15:00","doi":"10.21203/rs.3.rs-1236531/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"80b77ecc-c905-458e-bd76-a5a95bd571ce","owner":[],"postedDate":"February 9th, 2022","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2022-02-09T21:15:00+00:00","versionOfRecord":[],"versionCreatedAt":"2022-02-09 21:15:00","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-1236531","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-1236531","identity":"rs-1236531","version":["v1"]},"buildId":"_2-kVJe1T_tPrBINL-cwx","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: preprint-html

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00